Back to CVE records
Medium 6.5Published Jun 18, 2026
CVE-2026-52866Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT Missing Authorization
Updated under an hour ago ()
Does this affect you?
It affects Apollo Pharmacy Blood Glucose Monitoring System (Model No. APG-01 BT). Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Start free and add your stack
Free account, 1 product
An attacker within BLE communication range can monopolize the device's only available BLE connection slot, preventing legitimate users or applications from establishing a connection.
- CVSS
- 6.5 MEDIUM (v3.1, CNA)CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
- Weakness (CWE)
- CWE-862
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- icscert
- NVD analysis
- Awaiting Analysis
- Record last updated
- Jun 22, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
Apollo Pharmacy Blood Glucose Monitoring System (Model No. APG-01 BT) apollo_pharmacy:blood_glucose_monitoring_system_model_no_apg_01_bt (from the name) | 0x0110_v1.1.0 | CNA record |
References
- https://www.apollopharmacy.in/contact-us
- https://www.cisa.gov/news-events/news/understanding-bluetooth-technology
- https://www.cisa.gov/news-events/ics-medical-advisories/icsma-26-169-01
- https://github.com/cisagov/CSAF/blob/develop/csaf_files/OT/white/2026/icsma-26-169-01.json
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.